RAPIDLY EMERGING ANTIVIRAL DRUG DEVELOPMENT INITIATIVE- AVIDD CENTER (READDI-AC) - PROGRAM SUMMARY/ABSTRACT EMERGING VIRUSES ARISE SUDDENLY AND CAUSE CONSIDERABLE MORBIDITY AND MORTALITY WORLDWIDE. TO PREPARE FOR CURRENT AND FUTURE THREATS, PUBLIC-PRIVATE PARTNERSHIPS ARE NEEDED TO CHANGE THE CURRENT REACTIVE RESPONSE PLATFORM INTO ONE THAT IS PROACTIVE. IN RESPONSE TO RFA-AI-21-050, THE RAPIDLY EMERGING ANTIVIRAL DRUG DEVELOPMENT INITIATIVES AVIDD CENTER (READDI-AC) IS AN INTEGRATED PUBLIC-PRIVATE PARTNERSHIP WITH A RENOWNED, INTERDISCIPLINARY RESEARCH TEAM OF EXPERTS, WHO APPLY CUTTING EDGE INNOVATIVE TECHNOLOGIES IN VIROLOGY, BIOCHEMISTRY, STRUCTURAL BIOLOGY, MEDICINAL CHEMISTRY, COMPUTATIONAL BIOLOGY, STRUCTURE-GUIDED DRUG DESIGN AND GENOMICS TO DEVELOP ORAL, POTENT, BROAD-SPECTRUM FAMILY-SPECIFIC ANTIVIRALS FOR CORONAVIRUSES, FLAVIVIRUSES, ALPHAVIRUSES AND FILOVIRUSES. TO ACHIEVE THESE GOALS, THE READDI-AC PROGRAM INCLUDES ACADEMIC LEADERS IN BASIC AND APPLIED ANTIVIRAL RESEARCH A

Summary

RAPIDLY EMERGING ANTIVIRAL DRUG DEVELOPMENT INITIATIVE- AVIDD CENTER (READDI-AC) - PROGRAM SUMMARY/ABSTRACT EMERGING VIRUSES ARISE SUDDENLY AND CAUSE CONSIDERABLE MORBIDITY AND MORTALITY WORLDWIDE. TO PREPARE FOR CURRENT AND FUTURE THREATS, PUBLIC-PRIVATE PARTNERSHIPS ARE NEEDED TO CHANGE THE CURRENT REACTIVE RESPONSE PLATFORM INTO ONE THAT IS PROACTIVE. IN RESPONSE TO RFA-AI-21-050, THE RAPIDLY EMERGING ANTIVIRAL DRUG DEVELOPMENT INITIATIVES AVIDD CENTER (READDI-AC) IS AN INTEGRATED PUBLIC-PRIVATE PARTNERSHIP WITH A RENOWNED, INTERDISCIPLINARY RESEARCH TEAM OF EXPERTS, WHO APPLY CUTTING EDGE INNOVATIVE TECHNOLOGIES IN VIROLOGY, BIOCHEMISTRY, STRUCTURAL BIOLOGY, MEDICINAL CHEMISTRY, COMPUTATIONAL BIOLOGY, STRUCTURE-GUIDED DRUG DESIGN AND GENOMICS TO DEVELOP ORAL, POTENT, BROAD-SPECTRUM FAMILY-SPECIFIC ANTIVIRALS FOR CORONAVIRUSES, FLAVIVIRUSES, ALPHAVIRUSES AND FILOVIRUSES. TO ACHIEVE THESE GOALS, THE READDI-AC PROGRAM INCLUDES ACADEMIC LEADERS IN BASIC AND APPLIED ANTIVIRAL RESEARCH A